ArticleOncotarget2017

Concomitant inhibition of receptor tyrosine kinases and downstream AKT synergistically inhibited growth of KRAS/BRAF mutant colorectal cancer cells.

Qiaoling Song et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.